Ghent University Academic Bibliography

Journal Article
A1
open access

Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer : results of the MIMOSA trial

V C M Geurts, L Voorwerk, S Balduzzi, R Salgado, Koen Van de Vijver (UGent) , M G J van Dongen, I Kemper, I A M Mandjes, M Heuver, W Sparreboom, et al.

(2023) BREAST. 70. p.76-81

Add to list

Journal Article
A1
open access

Safety of pre- or postoperative accelerated radiotherapy in 5 fractions : a randomized pilot trial

Vincent Vakaet (UGent) , Hans Vanhulle, Koen Van de Vijver (UGent) , Ingeborg Hilderson, Eline Naert (UGent) , Wilfried De Neve (UGent) , Jo Van Dorpe (UGent) , An Hendrix (UGent) , Menekse GOKER (UGent) , Herman Depypere (UGent) , et al.

(2022) BREAST. 62. p.10-15

Add to list

Journal Article
A1
open access

Acute toxicity and health-related quality of life after accelerated whole breast irradiation in 5 fractions with simultaneous integrated boost

Hans Van Hulle, Vincent Vakaet (UGent) , Christel Monten (UGent) , Pieter Deseyne, Max Schoepen (UGent) , Cato Colman, Leen Paelinck (UGent) , Annick Van Greveling (UGent) , Giselle Post (UGent) , Bruno Speleers (UGent) , et al.

(2021) BREAST. 55. p.105-111

Add to list

Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery : study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment)

MEM van der Noordaa, FH van Duijnhoven, CE Loo, E van Werkhoven, Koen Van de Vijver (UGent) , T Wiersma, HAO Winter-Warnars, GS Sonke and MTFD Vrancken Peeters

(2018) BREAST. 40. p.76-81

Add to list

Physical activity levels after treatment for breast cancer : two-year follow-up

An De Groef, Inge Geraerts, Heleen Demeyer (UGent) , Elien Van der Gucht, Lore Dams, Carlijn de Kinkelder, Sanne Dukers-van Althuis, Marijke Van Kampen and Nele Devoogdt

(2018) BREAST. 40. p.23-28

Add to list

A plea for appraisal and appreciation of immunohistochemistry in the assessment of prognostic and predictive markers in invasive breast cancer

Mieke Van Bockstal (UGent) , Giuseppe Floris, Christine Galant, Kathleen Lambein and Louis Libbrecht

(2017) BREAST. 37. p.52-55

Add to list

A JAK3/STAT3 passenger activation in a lapatinib-acquired resistance model of HER2-amplified breast cancer

Mieke Van Bockstal (UGent) , Nadine Van Roy (UGent) , Glenn Vergauwen (UGent) , Kathleen Lambein (UGent) , Veronique Cocquyt (UGent) , Louis Libbrecht, Hannelore Denys (UGent) , marc bracke and Olivier De Wever (UGent)

(2017) BREAST. 32(suppl. 1). p.S48-S48

Add to list

Systematic review: The oncological safety of adipose fat transfer after breast cancer surgery

Karl Waked, Julien Colle, Maarten Doornaert, Veronique Cocquyt (UGent) and Phillip Blondeel (UGent)

(2017) BREAST. 31. p.128-136

Add to list

DIEAP flap for safe definitive autologous breast reconstruction

Katrin Seidenstuecker, CARL VAN WAES (UGent) , Beatrix I Munder, Karel Claes (UGent) , Christian Witzel, Nathalie Roche (UGent) , Filip Stillaert (UGent) , Ajay L Mahajan, Christoph Andree and Phillip Blondeel (UGent)

(2016) BREAST. 26. p.59-66

Add to list

Prognostic features of breast cancer differ between women in the Democratic Republic of Congo and Belgium

Gertrude Luyeye Mvila, Donatien Batalansi, Marleen Praet, Guy Marchal, Annouschka Laenen, Marie-Rose Christiaens, Olivier Brouckaert, Catherine Ali-Risasi (UGent) , Patrick Neven and Chantal Van Ongeval

(2015) BREAST. 24(5). p.642-648

Academic Bibliography

Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer : results of the MIMOSA trial

Safety of pre- or postoperative accelerated radiotherapy in 5 fractions : a randomized pilot trial

Acute toxicity and health-related quality of life after accelerated whole breast irradiation in 5 fractions with simultaneous integrated boost

Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery : study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment)

Physical activity levels after treatment for breast cancer : two-year follow-up

A plea for appraisal and appreciation of immunohistochemistry in the assessment of prognostic and predictive markers in invasive breast cancer

A JAK3/STAT3 passenger activation in a lapatinib-acquired resistance model of HER2-amplified breast cancer

Systematic review: The oncological safety of adipose fat transfer after breast cancer surgery

DIEAP flap for safe definitive autologous breast reconstruction

Prognostic features of breast cancer differ between women in the Democratic Republic of Congo and Belgium

Contents

Support

Contact